| CPC A61N 1/086 (2017.08) [A61B 18/00 (2013.01); A61N 1/36038 (2017.08); A61N 1/36053 (2013.01); A61N 1/36125 (2013.01); A61N 1/36153 (2013.01); A61N 1/3629 (2017.08); A61N 1/3718 (2013.01); A61N 1/39622 (2017.08); A61N 2/002 (2013.01); A61N 2/006 (2013.01); H02M 3/07 (2013.01); H03K 5/1252 (2013.01); H03K 5/24 (2013.01); A61B 2018/00577 (2013.01); A61M 31/002 (2013.01)] | 8 Claims |

|
1. A method of mitigating electromagnetic interference (EMI) in an implantable medical device (IMO) having a pulse generator configured to supply stimulation to tissue of a patient, the method comprising:
monitoring an interference voltage sensed at a Kelvin connection node associated with an implantable lead system of the IMO; and
generating one or more control signals to adjust a common-mode voltage reference output by a charge pump voltage source of the IMO depending on a difference between the common-mode voltage reference and the interference voltage sensed at the Kelvin connection node, wherein the one or more control signals comprise at least a first control signal generated responsive to determining that the interference voltage is greater than the common-mode voltage reference by a first threshold, the first control signal comprising a control signal operative to decrease the common-mode voltage reference output of the charge pump voltage source.
|